ARQQ vs AVGO
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ARQQ's Piotroski F-Score of 4/9 indicates weak financial health, with significant red flags in profitability and cash flow despite a strong current ratio and low debt. The company exhibits extreme negative operating margins (-6,589%) and ROE (-181.44%), signaling severe operational inefficiency. Although the Graham Number and intrinsic value are unavailable, the stock trades at an astronomical Price/Sales of 402.52, far exceeding sector averages and suggesting extreme overvaluation. The 52-week price drop of 94.3% and persistent negative earnings underscore deep market skepticism. Analysts have only one rating with a $60 target, but the stock remains vastly overpriced relative to fundamentals.
AVGO shows bullish fundamentals based on deterministic rules. Financial strength is stable (F-Score 4/9). Key strengths include strong valuation and growth metrics. Price trades at a 104.1% premium to fair value estimate ($151.63), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
ARQQ vs AVGO: Head-to-Head Comparison
This page compares Arqit Quantum Inc. (ARQQ) and Broadcom Inc. (AVGO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.